Status: Recruiting
ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
This study aims to investigate 68Ga-MY6349, an immune-PET tracer targeting trophoblast cell surface antigen 2 (Trop2), for the noninvasive diagnosis of craniopharyngioma in vivo.
Participants needed: 20
Trial details
Age: 14-80Biological sex: AllType: InterventionalSponsor: Deling LiUpdated: Sep 17, 2025Locations: 1
Eligibility criteria
must be able to provide a written informed consent [+2]
concomitant major central nervous system disorders [+4]